Xencor | XNCR - Operating Expenses

Stock Price
12.98
Daily Change
0.53 4.26%
Monthly
4.68%
Yearly
23.50%
Q2 Forecast
12.70

Xencor reported $81.86M in Operating Expenses for its fiscal quarter ending in December of 2025.





Operating Expenses Change Date
AbbVie USD 10.81B 13.45B Dec/2025
Alnylam Pharmaceuticals USD 965.32M 84.27M Dec/2025
Amgen USD 5.9B 773M Dec/2025
Arrowhead Research USD 223.22M 10.86M Dec/2025
AstraZeneca USD 12.53B 4.16B Dec/2025
Biogen USD 1.88B 81.4M Sep/2025
Bristol-Myers Squibb USD 8.3B 10.25B Dec/2025
Cytokinetics USD 196.12M 27.43M Dec/2025
GlaxoSmithKline GBP 7.18B 1.42B Dec/2025
J&J USD 17.44B 1.53B Mar/2026
Karyopharm Therapeutics USD 51.92M 9.9M Dec/2025
MacroGenics USD 53.32M 13.68M Dec/2025
Merck USD 10.16B 558M Dec/2025
Novartis USD 9.8B 61M Dec/2025
Pfizer USD 12.91B 79.89B Dec/2025
Regeneron Pharmaceuticals USD 2.99B 27.97B Dec/2025
Roche Holding CHF 21.01B 10.84B Dec/2025
Xencor USD 81.86M 13.35M Dec/2025